Skip to content

Intangibles (Net) at other companies

Axogen logo
AxogenAXGN
$7.27M+23.6%
Globus Medical logo
Globus MedicalGMED
$720.85M-6.6%
Medtronic logo
MedtronicMDT
$10.15B-13.0%
STERIS logo
STERISSTE
$1.62B-12.6%
ITG
Integer HoldingsITGR
$716.05M-6.5%
LeMaitre Vascular logo
LeMaitre VascularLMAT
$31.67M-7.9%

Other financials

Income statement

See full
Revenue$391.9M+2.4%
Gross profit$217.0M+11.6%
Operating income$11.5M+174%
Net income-$4.6M+81.7%
EPS (diluted)-$0.06+81.8%

Balance sheet

See full
Cash & equivalents$236.8M-1.0%
Total debt$2.0B+3.2%
Total equity$1.0B-31.6%
Total assets$3.6B-11.7%

Cash flow

See full
Operating cash flow$9.8M+187%
CapEx$14.8M-48.7%
Free cash flow-$5.0M+87.4%

Valuation

See full
Market cap$1.38B-56.8%
Enterprise value$3.12B-26.7%
P/S0.8×-1.1×

Profitability

See full
Gross margin51.9%-1.6pp
Operating margin-29.8%-30.3pp
Net margin-30.1%
FCF margin3.8%-6.3pp

Returns & leverage

See full
Return on equity-38.6%
Debt / equity1.9×+0.6×
Current ratio3.4×+2.2×

Where this comes from

Reported directly by Integra LifeSciences in its filing.

Tagged under the XBRL concept us-gaap:IntangibleAssetsNetExcludingGoodwill.

The official record: Integra LifeSciences’s 10-Q, filed May 5, 2026, on SEC EDGAR. View the filing →

Ask your AI about Integra LifeSciences's intangibles (net).

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Integra LifeSciences's intangibles (net)?
Integra LifeSciences (IART) reported intangibles (net) of $1.11B in Q1 2026.
How has Integra LifeSciences's intangibles (net) changed year-over-year?
Integra LifeSciences's intangibles (net) decreased by 6.9% year-over-year, from $1.19B to $1.11B.
What is the long-term trend for Integra LifeSciences's intangibles (net)?
Over 5 years (2020 to 2025), Integra LifeSciences's intangibles (net) has grown at a 2.8% compound annual growth rate (CAGR), from $989.44M to $1.13B.
What does intangibles (net) mean?
Identifiable intangible assets (patents, trademarks, customer relationships, technology) net of accumulated amortization — excluding goodwill.